Provided by Tiger Trade Technology Pte. Ltd.

Trane Technologies PLC

448.96
-5.3500-1.18%
Post-market: 448.960.00000.00%19:58 EDT
Volume:728.23K
Turnover:327.25M
Market Cap:98.78B
PE:34.03
High:456.99
Open:452.80
Low:446.26
Close:454.31
52wk High:505.87
52wk Low:348.06
Shares:220.02M
Float Shares:220.02M
Volume Ratio:0.63
T/O Rate:0.33%
Dividend:3.98
Dividend Rate:0.89%
EPS(TTM):13.19
EPS(LYR):12.98
ROE:36.64%
ROA:11.00%
PB:11.46
PE(LYR):34.60

Loading ...

Trane Technologies PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 29

Carrier Global Corp. Stock Slips 8.9%, Underperforms Peers

Dow Jones
·
Jul 29

The Bull Case For Trane Technologies (TT) Could Change Following Supply Chain Chief’s Planned Exit

Simply Wall St.
·
Jul 24

Earning Preview: Trane Technologies PLC revenue expected to increase by 7.30%, institutional views lean constructive

Earnings Agent
·
Jul 24

Baird Raises Trane Technologies Price Target to $532 From $515, Maintains Neutral Rating

MT Newswires Live
·
Jul 23

Carrier Global Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 23

Trane Technologies Bdrs in Brazil Undergo 20-for-1 Stock Split After Ratio Change

Reuters
·
Jul 23

Moog Extends Taiwan Distribution Agreement with AIDC Through 2031

Reuters
·
Jul 21

Geely Galaxy TT Ultra opens pre-sales in China at about $30,900

CnEVPost
·
Jul 21

Carrier Global Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Trane Technologies PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 17

Trane Technologies BDR Ratio Shifts to 1:40 in 20-for-1 Stock Split Adjustment

Reuters
·
Jul 16

Carrier Global Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 14

TransThera's TT-00973 Cleared for China Phase 2 Lung Cancer Trial

MT Newswires Live
·
Jul 13

Trane Technologies PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 11

TransThera Wins NMPA Nod for Phase II Lung Cancer Trial of TT-00973 Combo

TIPRANKS
·
Jul 10

TRANSTHERA-B Receives Regulatory Nod for Phase II Trial of TT-00973 in Combination with Furmonertinib for NSCLC

Stock News
·
Jul 10

Goldman Sachs Adjusts Price Target on Trane Technologies to $539 From $532

MT Newswires Live
·
Jul 10

Trane Technologies Schedules Q2 Earnings Conference Call

Reuters
·
Jul 09

Bernstein Adjusts Price Target on Trane Technologies to $555 From $550

MT Newswires Live
·
Jul 09